Find policies, billing codes, payers, states, and providers
Loading...
Find policies, billing codes, payers, states, and providers
CPT 87260: Adenovirus Antigen Detection by Immunofluorescence
CPT-87265-BORDETELLA-IMMUNOFLUORESCENT-ANTIGEN-DETECTIONCPT 87265: Bordetella Antigen Detection by Immunofluorescence
CPT-87267-ENTEROVIRUS-DFA-ANTIGEN-DETECTIONCPT 87267: Enterovirus Antigen Detection by DFA
CPT-87269-GIARDIA-IMMUNOFLUORESCENT-ANTIGEN-DETECTIONCPT 87269: Giardia Antigen Detection by Immunofluorescence
CPT-87270-CHLAMYDIA-TRACHOMATIS-IMMUNOFLUORESCENT-ANTIGEN-DETECTIONCPT 87270: Chlamydia trachomatis Antigen Detection by Immunofluorescence
CPT-87271-CMV-DFA-ANTIGEN-DETECTIONCPT 87271: CMV Antigen Detection by Direct Fluorescent Antibody
CPT-87272-CRYPTOSPORIDIUM-IMMUNOFLUORESCENT-ANTIGEN-DETECTIONCPT 87272: Cryptosporidium Antigen Immunofluorescent Test
CPT-87273-HSV-2-ANTIGEN-IMMUNOFLUORESCENCECPT 87273: HSV-2 Antigen Detection by Immunofluorescence
CPT-87274-HSV-1-ANTIGEN-IMMUNOFLUORESCENCECPT 87274: HSV-1 Antigen Detection by Immunofluorescence
CPT-87275-INFLUENZA-B-IMMUNOFLUORESCENT-ANTIGEN-DETECTIONCPT 87275: Influenza B Antigen Detection by Immunofluorescence
Showing 1–10 of 168
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.